June 19, 2024 00:14 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Portion of under-construction bridge collapses in Bihar's Araria | PM Modi performs Ganga aarti in Varanasi on his first visit since LS polls victory | Mamata Banerjee calls on BJP MP Anant Maharaj in Coochbehar, triggers speculation | Darshan Thoogudeepa's drivers went for shopping after murdering Renukaswamy, reveals probe | Ajit Pawar camp's 18-19 MLAs ready for crossover: Sharad Pawar's grand-nephew Rohit Pawar
MSN Group launches urinary incontinence drug
MSN Labs
MSN Groups Facebook page

MSN Group launches urinary incontinence drug

| @indiablooms | 22 Mar 2023, 06:32 pm

Kolkata: MSN Labs, a research-based and fully-integrated global pharmaceutical company based out of Hyderabad, announced the launch of Fesobig, a bio-equivalent generic version of Fesoterodine Fumarate.

The company said Fesobig has been recommended as the safest, novel first line pharmacotherapy option by various international treatment guidelines for the treatment of overactive bladder (OAB) and Uninary Incontinence (UI).

“The launch of Fesobig (Fesoterodine) tablets is in line with our ongoing commitment to research in bringing affordable medications across critical therapies for alleviating the suffering of the Indian patients.” M.S.N. Reddy, Chairman & Managing Director, MSN Group commented.

Speaking on occasion, Bharat Reddy, Executive Director, MSN Group, said, “Besides helping recover from overactive bladder (OAB), we are certain that Fesobig will endow patients with a much confident way of life by eliminating the social and psychological discomfort associated with the condition. We have ensured that drug is priced affordably so that it can benefit a vast majority of patients.”

The guest speaker Dr K Lalitha, consultant urologist, spoke on the prevalence of OAB in India. According to the studies,1 in 3 women above the age of 50 suffers from urinary incontinence impacting their quality of life.

Anuradha Koduri, HOD - Gynecology, KIMS Hospital, spoke on the social stigma associated with the condition and stated that a majority of patients shy away from treatment due to the lack of awareness and accept it as a part of ageing process.This, in the long run,leads to various medical complications.

A V Ravikumar, consultant urologist further elucidated on the various medical avenues including behavioral therapy, drugs and surgical options available in treating OAB.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.